Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia.

Shalabi, Haneen; Angiolillo, Anne; Fry, Terry J

Shalabi, Haneen; Angiolillo, Anne; Fry, Terry J.

Afiliação

Shalabi H; Center for Cancer and Blood Disorders, Children's National Medical Center , Washington, DC , USA.
Angiolillo A; Center for Cancer and Blood Disorders, Children's National Medical Center , Washington, DC , USA.
Fry TJ; Hematologic Malignancies Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD , USA.

Front Pediatr ; 3: 80, 2015.

Article em En | MEDLINE | ID: mdl-26484338

Palavras-chave

adoptive; chimeric antigen receptor; chimeric antigen receptor safety; immunotherapy; pediatric acute leukemia; relapsed leukemia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pediatr Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google